Raymond James Financial Services Advisors Inc. Sells 50,022 Shares of Encompass Health Co. (NYSE:EHC)

Raymond James Financial Services Advisors Inc. lowered its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 38.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 81,130 shares of the company's stock after selling 50,022 shares during the period. Raymond James Financial Services Advisors Inc. owned approximately 0.08% of Encompass Health worth $5,413,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. C M Bidwell & Associates Ltd. acquired a new stake in Encompass Health during the 3rd quarter valued at $35,000. Worth Asset Management LLC acquired a new stake in Encompass Health during the 1st quarter valued at $35,000. Belpointe Asset Management LLC raised its stake in Encompass Health by 88.2% during the 1st quarter. Belpointe Asset Management LLC now owns 781 shares of the company's stock valued at $42,000 after purchasing an additional 366 shares during the period. Quarry LP acquired a new stake in Encompass Health during the 1st quarter valued at $42,000. Finally, Benjamin Edwards Inc. raised its stake in Encompass Health by 89.0% during the 2nd quarter. Benjamin Edwards Inc. now owns 1,087 shares of the company's stock valued at $74,000 after purchasing an additional 512 shares during the period. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Up 2.9 %

NYSE:EHC traded up $2.35 during trading hours on Friday, reaching $83.35. The company's stock had a trading volume of 867,088 shares, compared to its average volume of 657,085. The company has a market cap of $8.35 billion, a price-to-earnings ratio of 24.02, a price-to-earnings-growth ratio of 1.52 and a beta of 0.94. Encompass Health Co. has a one year low of $57.55 and a one year high of $83.73. The business's 50-day moving average is $75.71 and its 200-day moving average is $69.47. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.28.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.12. The firm had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.24 billion. Encompass Health had a net margin of 7.33% and a return on equity of 17.69%. Equities research analysts predict that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, April 15th. Shareholders of record on Monday, April 1st will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend is Thursday, March 28th. Encompass Health's dividend payout ratio (DPR) is 17.29%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. William Blair reissued an "outperform" rating on shares of Encompass Health in a research note on Wednesday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $83.00 price target on shares of Encompass Health in a research note on Friday, February 9th. Stephens reaffirmed an "overweight" rating and issued a $85.00 price target on shares of Encompass Health in a research note on Tuesday, January 16th. Barclays upped their price target on shares of Encompass Health from $95.00 to $101.00 and gave the stock an "overweight" rating in a research note on Thursday, March 28th. Finally, Truist Financial upped their price target on shares of Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a research note on Friday, February 9th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Encompass Health has an average rating of "Buy" and a consensus price target of $83.22.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.